Literature DB >> 31564171

An exploratory investigation of apoptotic and autophagic responses in peripheral blood mononuclear cells following maximal aerobic exercise in obese individuals.

Chun-Jung Huang1, Alexandra L Rodriguez1, Nishant P Visavadiya1, Brandon G Fico2, Aaron L Slusher3, Peter J Ferrandi4, Michael Whitehurst1.   

Abstract

Autophagy is a critical molecular process in promoting cell survival against apoptosis. This study examined whether maximal aerobic exercise-mediated apoptosis in obesity might be underlying the involvement of autophagy in the peripheral blood mononuclear cells (PBMCs). Twelve healthy male subjects (6 obese and 6 normal-weight) were recruited to participate in a maximal graded exercise test on a treadmill. Obese subjects exhibited a significantly lower Bax, but a higher Bcl-2 protein level in conjunction with a reduced Bax/Bcl-2 AUCi compared to normal-weight subjects following exercise. Furthermore, a greater LC3-II/LC3-I ratio and LC3-II/LC3-I AUCi was observed in obese subjects compared to normal-weight subjects. LC3-II/LC3-I AUCi was also positively associated with obesity-associated parameters (BMI, waist/hip circumference, and fasting insulin level), but was negatively correlated with Bax/Bcl-2 AUCi. These findings demonstrate that maximal aerobic exercise differentially mediates the intrinsic apoptotic pathway and autophagic activity in human PBMCs isolated from obese compared to normal-weight individuals.

Entities:  

Keywords:  Exercise; apoptosis; autophagy; obesity; physical activity

Mesh:

Year:  2019        PMID: 31564171     DOI: 10.1080/13813455.2019.1671875

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  1 in total

1.  Lymphocytes are less sensitive to autophagy than monocytes during fasting and exercise conditions.

Authors:  Arno Schmidt-Trucksäss; Marijke Brink; Julia M Kröpfl; Christian Morandi; Benedikt A Gasser; Raphael Schoch
Journal:  Apoptosis       Date:  2022-07-19       Impact factor: 5.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.